Main Management ETF Advisors LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 17,848 shares of the company's stock, valued at approximately $935,000.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Great Valley Advisor Group Inc. acquired a new stake in Astera Labs in the second quarter worth about $443,000. Bank of New York Mellon Corp acquired a new stake in shares of Astera Labs in the 2nd quarter worth approximately $8,361,000. Legato Capital Management LLC bought a new position in shares of Astera Labs in the second quarter valued at approximately $207,000. Strategic Blueprint LLC bought a new position in shares of Astera Labs in the second quarter valued at approximately $332,000. Finally, Essex Financial Services Inc. acquired a new position in shares of Astera Labs during the second quarter valued at approximately $1,304,000.
Insider Buying and Selling
In other Astera Labs news, insider Sanjay Gajendra sold 76,701 shares of the business's stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $45.32, for a total value of $3,476,089.32. Following the transaction, the insider now owns 855,000 shares in the company, valued at $38,748,600. The trade was a 8.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stefan A. Dyckerhoff sold 50,000 shares of the firm's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total value of $4,485,000.00. Following the sale, the director now directly owns 129,617 shares of the company's stock, valued at $11,626,644.90. This trade represents a 27.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,154,820 shares of company stock worth $195,106,438.
Analysts Set New Price Targets
ALAB has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Craig Hallum raised their target price on Astera Labs from $75.00 to $105.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Barclays lifted their target price on Astera Labs from $70.00 to $87.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Morgan Stanley upped their price target on shares of Astera Labs from $74.00 to $94.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. Finally, Roth Mkm lifted their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the stock a "buy" rating in a research note on Tuesday, November 5th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $94.67.
Get Our Latest Stock Report on ALAB
Astera Labs Stock Performance
Shares of Astera Labs stock traded up $5.72 during trading on Friday, hitting $120.40. The stock had a trading volume of 4,065,807 shares, compared to its average volume of 5,095,545. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $121.20. The stock has a 50 day simple moving average of $80.04 and a 200 day simple moving average of $62.15.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm had revenue of $113.10 million during the quarter, compared to the consensus estimate of $97.50 million. The firm's quarterly revenue was up 47.1% on a year-over-year basis. As a group, equities research analysts predict that Astera Labs, Inc. will post -0.45 EPS for the current year.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.